Companies · Other Health Care
BELLEVUE · Other Health Care
Diligence memoA one-page analyst read on Aegis Impact & Innovation LLC — recommendation, valuation, rhythm, risks.→Aegis Impact & Innovation LLC looks fair against its niche peers and is quiet on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
Aegis Impact & Innovation LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Aegis Impact & Innovation LLC is one of 5377 Other Health Care companies tracked from BELLEVUE. By capital raised it ranks mid-pack (ahead of 57% of sector peers), and in the long tail by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.
Round size and date are reported; the stage label is inferred from round size (latest is Seed — a $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 57% of sector peers (real $). Modeled value above 38% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #120 of 244.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Elmntri LLC | Seed | $4.0M | $46.1M | 3.83× |
| Atreo, Inc. | Seed | $3.8M | $42.1M | 3.50× |
| descendantsDNA, Inc. | Seed | $3.4M | $40.8M | 3.40× |
| Westover Project Investor LLC | Seed | $4.0M | $40.0M | 3.33× |
| Dentulu Inc | Seed | $6.4M | $37.7M | 3.13× |
| Emmacare.com LLC | Seed | $3.0M | $37.2M | 3.10× |
| IR-Med, Inc. | Seed | $5.4M | $37.0M | 3.08× |
| SDH Parent 2 LLC | Seed | $3.0M | $36.7M | 3.05× |
| TecTraum, Inc. | Seed | $7.8M | $36.7M | 3.05× |
| DBN BCS II Investments, LLC | Seed | $3.0M | $34.0M | 2.83× |
| USRC Baldwin Hills, LLC | Seed | $2.8M | $34.0M | 2.82× |
| Flex Operating Room, Inc. | Seed | $6.2M | $31.9M | 2.65× |
| Aegis Impact & Innovation LLC this company | Seed | $3.4M | $12.3M | 1.02× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Seed | $3.4M | 2024-12-11 | $16.8M | $12.3M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Dwayne J. Clark | — | 12 other | 2024-12 |
Aegis Impact & Innovation LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| ASC Ravenna LLC | Other Health Care | Seed | $3.6M | $90.5M | network1 shared operator · same sector · same stage |
| ASC Marymoor LLC | Other Health Care | Seed | $2.7M | $67.2M | network1 shared operator · same sector · same stage |
| ASC Rodgers Park LLC | Other Health Care | Seed | $1.9M | $47.8M | network1 shared operator · same sector · same stage |
| ASC Mercer Island LLC | Other Health Care | Seed | $1.9M | $47.7M | network1 shared operator · same sector · same stage |
| ASC Madison LLC | Other Health Care | Seed | $1.3M | $32.8M | network1 shared operator · same sector · same stage |
| Prairie View Assisted Living, Llc | Other Health Care | Seed | $3.3M | $13.3M | same sector · same stage |
| ASC Admiral Way LLC | Other Health Care | Series A | $4.1M | $83.5M | network1 shared operator · same sector |
| VedaPointe, LLC | Other Health Care | Seed | $3.4M | $11.8M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Aera Imaging Resources, LLC | Other Health Care | Pre-Seed | $649K | 84% |
| Lapovations LLC | Other Health Care | Pre-Seed | $2.1M | 84% |
| Aerin Medical Inc. | Healthtech | Series C | $243.4M | 83% |
| Hospital Innovations, LLC | Other Health Care | Seed | $18.1M | 83% |
| Innovatel, LLC | Other Health Care | Pre-Seed | $30.8M | 83% |
| eHealth, Inc. | Other Health Care | Series D+ | $4.4B | 82% |
| Innovation Specialists Llc | Other Health Care | Seed | $15.5M | 82% |
| AHS Ventures | Other Health Care | Series C | $405.2M | 81% |
See where Aegis Impact & Innovation LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Aegis Impact & Innovation LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.